tiprankstipranks
Trending News
More News >
Olaplex Holdings (OLPX)
NASDAQ:OLPX
US Market
Advertisement

Olaplex Holdings (OLPX) AI Stock Analysis

Compare
244 Followers

Top Page

OLPX

Olaplex Holdings

(NASDAQ:OLPX)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 4o)
Rating:52Neutral
Price Target:
$1.00
▼(-7.41% Downside)
Olaplex Holdings faces significant challenges with profitability and operational efficiency, reflected in a low valuation score. While technical indicators suggest bearish momentum, positive cash flow trends and strategic marketing investments provide some optimism for future growth.
Positive Factors
Innovative Product Launches
The launch of new products, especially in fast-growing niches, can drive revenue growth and strengthen market position, enhancing long-term competitiveness.
Professional Channel Growth
Growth in the professional channel indicates strong demand and brand loyalty among salons, supporting sustained revenue and market leadership.
Strong Direct-to-Consumer Performance
Robust direct-to-consumer sales growth reflects effective marketing and customer engagement, which can lead to higher margins and brand loyalty.
Negative Factors
Decline in Specialty Retail Sales
A decline in specialty retail sales suggests challenges in retail distribution and consumer reach, potentially impacting overall revenue growth.
Lower Adjusted EBITDA Margin
Decreasing EBITDA margins indicate rising costs and operational inefficiencies, which could affect profitability and cash flow if not addressed.
International Sales Decline
A decline in international sales highlights challenges in global market expansion, which could limit growth opportunities and diversification.

Olaplex Holdings (OLPX) vs. SPDR S&P 500 ETF (SPY)

Olaplex Holdings Business Overview & Revenue Model

Company DescriptionOlaplex Holdings, Inc. is a beauty and personal care company renowned for its innovative hair care products that focus on repairing and strengthening damaged hair. Founded in 2014, Olaplex operates primarily in the professional hair care sector, catering to both salons and consumers. Its flagship product line includes the patented Olaplex Bond Building Technology, which is designed to restore the internal strength and integrity of hair, making it a favorite among hairstylists and consumers alike. The company has expanded its offerings to include a variety of shampoos, conditioners, and styling treatments, solidifying its position as a leader in the hair care industry.
How the Company Makes MoneyOlaplex generates revenue primarily through the sale of its hair care products, which are distributed through professional salons and retail channels. The company operates a dual revenue model: direct sales to professional hair salons and sales through retail partners, including e-commerce platforms. Key revenue streams include sales of its core products, particularly the Olaplex No. 1 through No. 8 line, which has gained significant traction in both the professional and consumer markets. Additionally, Olaplex collaborates with salons to provide training and support for stylists, enhancing the brand's presence and driving product adoption. The company also benefits from a strong brand reputation and customer loyalty, which contribute to repeat purchases and sustained sales growth.

Olaplex Holdings Key Performance Indicators (KPIs)

Any
Any
Net Sales by Geography
Net Sales by Geography
Chart Insights
Data provided by:Main Street Data

Olaplex Holdings Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Mar 10, 2026
Earnings Call Sentiment Neutral
The earnings call showed signs of progress with positive net sales growth and successful product launches. However, challenges persist with declining retail sales, flat year-to-date performance, and reduced EBITDA margins. The company is heavily investing in marketing and operational strategies to drive long-term growth.
Q2-2025 Updates
Positive Updates
Positive Net Sales Growth
Net sales reached $106.3 million, marking a 2.3% increase year-over-year, driven by growth in direct-to-consumer and professional channels.
Strong Direct-to-Consumer Performance
Direct-to-consumer sales grew 12.8% year-over-year, supported by strategic marketing initiatives and website upgrades.
Innovative Product Launches
Three new products were launched in the first half of 2025, including a scalp longevity treatment, marking an entry into a fast-growing niche.
Record Marketing Investment
Investment in non-payroll sales and marketing increased by $14.6 million compared to the previous year, driving an improved brand presence.
Professional Channel Growth
The professional channel grew by 12.1% year-over-year, driven by strong U.S. performance and strategic market blitz initiatives.
Negative Updates
Decline in Specialty Retail Sales
Specialty retail sales decreased by 16.7% year-over-year in the second quarter, though there was sequential improvement in sell-through.
Flat Year-To-Date Net Sales
Year-to-date net sales remained flat, indicating ongoing challenges despite positive quarterly growth.
Lower Adjusted EBITDA Margin
Adjusted EBITDA margin decreased to 24.7% year-to-date, down from 33.3% the previous year, reflecting increased marketing and operational investments.
International Sales Decline
International sales were down low single digits year-to-date, reflecting ongoing challenges in executing the transformation strategy.
Company Guidance
During the Olaplex Holdings, Inc. second quarter 2025 earnings call, the company reported net sales of $106.3 million, marking a 2.3% increase year-over-year, and an adjusted EBITDA of $24.6 million, maintaining a 23.1% margin. The professional channel saw a 12.1% growth, driven mainly by the U.S. market, whereas specialty retail experienced a decline of 16.7%. Direct-to-consumer sales rose by 12.8%. The company's strategic focus included a $45.4 million investment in non-payroll sales and marketing, which contributed to achieving a 24.7% adjusted EBITDA margin year-to-date. The marketing strategies involved a rebranding initiative and targeted campaigns, resulting in increased social mentions by 35% and social impressions by 140%. Olaplex's guidance for the full year 2025 anticipates net sales to range from a 3% decline to a 2% increase compared to 2024, with an adjusted gross margin between 70.5% and 71.5%, and adjusted EBITDA margins of 20% to 22%. The company plans to focus on the fourth quarter for significant sales growth, driven by new product launches and strategic promotions.

Olaplex Holdings Financial Statement Overview

Summary
Olaplex Holdings shows strong gross margins and improved leverage, but faces profitability challenges with negative net profit margins and declining operational efficiency. Positive cash flow trends offer some optimism.
Income Statement
55
Neutral
Olaplex Holdings has shown a mixed performance in its income statement. The TTM data indicates a slight revenue growth of 0.56%, but the company is currently experiencing a negative net profit margin of -0.30%, indicating a loss. The gross profit margin remains strong at 68.90%, suggesting efficient production processes. However, the declining EBIT and EBITDA margins over the years highlight challenges in operational efficiency and cost management.
Balance Sheet
60
Neutral
The balance sheet shows a moderate financial position with a debt-to-equity ratio of 0.40 in the TTM, indicating a decrease in leverage compared to previous years. However, the return on equity is negative at -0.15%, reflecting the recent net loss. The equity ratio stands at 57.64%, suggesting a stable capital structure with a reasonable proportion of equity financing.
Cash Flow
65
Positive
Cash flow analysis reveals a positive trajectory with a free cash flow growth rate of 5.75% in the TTM. The operating cash flow to net income ratio is 0.84, indicating that the company generates sufficient cash from operations relative to its net income. The free cash flow to net income ratio is nearly 1, suggesting efficient cash conversion from profits.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue418.58M422.67M458.30M704.27M598.37M282.25M
Gross Profit288.96M292.29M318.63M519.55M481.81M179.59M
EBITDA68.70M143.39M186.77M398.96M385.70M131.78M
Net Income-4.95M19.52M61.59M244.07M220.78M39.28M
Balance Sheet
Total Assets1.51B1.77B1.74B1.70B1.56B1.33B
Cash, Cash Equivalents and Short-Term Investments286.38M585.97M466.40M322.81M186.39M10.96M
Total Debt352.10M650.46M655.77M662.77M758.20M775.48M
Total Liabilities625.47M893.32M895.37M916.72M1.04B802.16M
Stockholders Equity888.75M874.40M844.97M780.96M524.30M530.67M
Cash Flow
Free Cash Flow64.80M141.94M173.92M254.67M198.26M128.95M
Operating Cash Flow67.64M143.07M177.53M255.32M200.03M128.97M
Investing Cash Flow-2.85M-4.89M-3.61M-2.68M-6.26M-1.38B
Financing Cash Flow-314.29M-18.61M-30.33M-116.22M-18.34M1.26B

Olaplex Holdings Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.08
Price Trends
50DMA
1.28
Negative
100DMA
1.36
Negative
200DMA
1.36
Negative
Market Momentum
MACD
-0.07
Negative
RSI
39.37
Neutral
STOCH
26.27
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For OLPX, the sentiment is Negative. The current price of 1.08 is below the 20-day moving average (MA) of 1.13, below the 50-day MA of 1.28, and below the 200-day MA of 1.36, indicating a bearish trend. The MACD of -0.07 indicates Negative momentum. The RSI at 39.37 is Neutral, neither overbought nor oversold. The STOCH value of 26.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for OLPX.

Olaplex Holdings Risk Analysis

Olaplex Holdings disclosed 50 risk factors in its most recent earnings report. Olaplex Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Olaplex Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$1.40B7.7828.94%-0.38%35.78%
72
Outperform
$23.17B20.0048.52%2.94%4.57%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
59
Neutral
$4.88B7.033.53%-0.18%-18.95%
54
Neutral
$14.02B93.3134.48%9.04%-56.79%
53
Neutral
$5.75B42.141.98%-20.98%
52
Neutral
$680.42M-0.15%-3.43%-102.60%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
OLPX
Olaplex Holdings
1.08
-0.54
-33.33%
BBWI
Bath & Body Works
22.66
-8.28
-26.76%
SBH
Sally Beauty
13.76
0.68
5.20%
ULTA
Ulta Beauty
509.85
116.59
29.65%
ETSY
Etsy
56.80
3.39
6.35%
CHWY
Chewy
32.82
2.03
6.59%

Olaplex Holdings Corporate Events

Business Operations and StrategyM&A Transactions
Olaplex Holdings Acquires Purvala Bioscience for Innovation
Positive
Aug 26, 2025

On August 20, 2025, Olaplex Holdings, Inc. acquired Purvala Bioscience, a Boston-based biotech company, for $10.5 million. This acquisition marks OLAPLEX’s first since its inception over a decade ago, underscoring its commitment to innovation in the haircare industry. The integration of Purvala’s bioinspired technologies is expected to enhance OLAPLEX’s product offerings, potentially leading to the development of next-generation, science-backed products. This strategic move is anticipated to strengthen OLAPLEX’s position in the market and benefit its stylist community and consumers.

The most recent analyst rating on (OLPX) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Olaplex Holdings stock, see the OLPX Stock Forecast page.

Olaplex Holdings, Inc. Earnings Call: Balancing Growth and Challenges
Aug 13, 2025

Olaplex Holdings, Inc. Navigates Transformation with Balanced Growth and Challenges

Olaplex Reports Mixed Q2 2025 Financial Results
Aug 8, 2025

Olaplex Holdings, Inc., a prominent player in the health and beauty sector, is known for its innovative hair care solutions, particularly its Complete Bond Technology™ that enhances hair strength and health. In its latest earnings report for the second quarter of 2025, Olaplex reported a modest increase in net sales by 2.3% to $106.3 million, despite a net loss of $7.7 million compared to a net income of $5.8 million in the same period last year. The company’s performance across different sales channels varied, with professional and direct-to-consumer channels showing growth, while specialty retail saw a decline.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025